Seleniso Medicare reimbursement details
Selinexor (Selinexor), as an innovative oral selective nuclear export inhibitor (SINE), relies on its unique mechanism of action to effectively inhibit the growth of cancer cells by blocking the nuclear export protein XPO1. It has become an important choice for the treatment of relapsed or refractory multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL), especially for those patients who do not respond to traditional treatments. It brings new hope.
Fortunately, Seleniso has been successfully approved for marketing in China and has been included in the national medical insurance directory. This move greatly reduces the financial pressure on patients and allows more patients to have the opportunity to receive this cutting-edge treatment option. Medical insurance coverage clearly covers the treatment of relapsed or refractory multiple myeloma, allowing more patients to benefit from this innovative therapy. For specific inclusion time and reimbursement conditions, patients must refer to the relevant regulations of the National Medical Insurance Bureau and local medical policies.
After being included in medical insurance, the price of Seleniso has dropped significantly compared with before. According to relevant reports, the cost of the drug after medical insurance is roughly in the range of 5,000 to 10,000 yuan. Of course, the specific cost will fluctuate due to hospital purchase prices and regional differences. Through medical insurance reimbursement, the actual payment amount of the patient will be significantly reduced, and the reimbursement ratio can generally reach 50%-80%. For the final personal payment cost, it is recommended that patients consult the local medical insurance department or hospital pharmacy to obtain accurate information.
The inclusion of selinesol in medical insurance undoubtedly provides strong support to patients and also greatly improves the accessibility of the drug. Before use, patients should carefully understand the medical insurance policy, reimbursement process and medication precautions, and strictly follow the doctor's instructions in order to achieve the best therapeutic effect.
Reference materials:https://en.wikipedia.org/wiki/Selinexor
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)